These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 33455488)

  • 1. Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation.
    Chen X; Li X; Xu X; Li L; Liang N; Zhang L; Lv J; Wu YC; Yin H
    Free Radic Res; 2021 Apr; 55(4):405-415. PubMed ID: 33455488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on lipid oxidation and inflammation in cardiovascular diseases.
    Zhong S; Li L; Shen X; Li Q; Xu W; Wang X; Tao Y; Yin H
    Free Radic Biol Med; 2019 Nov; 144():266-278. PubMed ID: 30946962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis.
    Jin S; Wang H; Zhang X; Song M; Liu B; Sun W
    Biomed Pharmacother; 2024 May; 174():116457. PubMed ID: 38518600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanisms of ferroptosis and its role in cardiovascular disease.
    Zhang Y; Xin L; Xiang M; Shang C; Wang Y; Wang Y; Cui X; Lu Y
    Biomed Pharmacother; 2022 Jan; 145():112423. PubMed ID: 34800783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Panoramic View of Ferroptosis in Cardiovascular Disease.
    Cheng X; Yu C; Yang X; Wang F; Min J
    Kidney Dis (Basel); 2023 May; 9(3):173-186. PubMed ID: 37497204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular diseases: oxidative damage and antioxidant protection.
    Zhang PY; Xu X; Li XC
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3091-6. PubMed ID: 25392110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis and its emerging roles in cardiovascular diseases.
    Li N; Jiang W; Wang W; Xiong R; Wu X; Geng Q
    Pharmacol Res; 2021 Apr; 166():105466. PubMed ID: 33548489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis as an emerging target in inflammatory diseases.
    Mao H; Zhao Y; Li H; Lei L
    Prog Biophys Mol Biol; 2020 Sep; 155():20-28. PubMed ID: 32311424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.
    Lin L; Zhang MX; Zhang L; Zhang D; Li C; Li YL
    Front Cell Dev Biol; 2021; 9():809955. PubMed ID: 35096837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding ferroptosis: Revealing the hidden assassin behind cardiovascular diseases.
    Zhang Z; Yang Z; Wang S; Wang X; Mao J
    Biomed Pharmacother; 2024 Jul; 176():116761. PubMed ID: 38788596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted role of ferroptosis in cardiovascular disease.
    Li C; Zhu X; Chen J; Xie X; Liang S; Liu X; Gong Q; Guo J
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):183-193. PubMed ID: 36815377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties.
    Agmon E; Solon J; Bassereau P; Stockwell BR
    Sci Rep; 2018 Mar; 8(1):5155. PubMed ID: 29581451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
    Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored.
    Huang F; Yang R; Xiao Z; Xie Y; Lin X; Zhu P; Zhou P; Lu J; Zheng S
    Front Cell Dev Biol; 2021; 9():737971. PubMed ID: 34527678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of ferroptosis in cardiovascular disease.
    Zeng Q; Jiang T
    Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38374233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis Inhibitors as Potential New Therapeutic Targets for Cardiovascular Disease.
    Shaghaghi Z; Motieian S; Alvandi M; Yazdi A; Asadzadeh B; Farzipour S; Abbasi S
    Mini Rev Med Chem; 2022; 22(17):2271-2286. PubMed ID: 35184711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential intervention target of atherosclerosis: Ferroptosis (Review).
    Li J; Xu L; Zuo YX; Chang XQ; Chi HT
    Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36148885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction?
    Stoyanovsky DA; Tyurina YY; Shrivastava I; Bahar I; Tyurin VA; Protchenko O; Jadhav S; Bolevich SB; Kozlov AV; Vladimirov YA; Shvedova AA; Philpott CC; Bayir H; Kagan VE
    Free Radic Biol Med; 2019 Mar; 133():153-161. PubMed ID: 30217775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid oxidation products in ferroptotic myocardial cell death.
    Stamenkovic A; Pierce GN; Ravandi A
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H156-H163. PubMed ID: 31050558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.